arXiv:2608. 15915v1 Announce Type: cross Abstract: Lung cancer remains the leading cause of cancer-related mortality worldwide, while histopathological diagnosis is often affected by inter-observer variability and the substantial workload associated with manual slide examination.
By Hadi Hasan, Safaa Salman, Lama Sleem, Ralph Mouawad, Ali Chehab
arXiv:2607. 22173v1 Announce Type: cross Abstract: Bowel obstruction is a common and potentially life-threatening gastrointestinal condition.
By Moritz Vandenhirtz, Andrea Agostini, Dana Belde, M\'elanie Roschewitz, Ismaiel Chikh Bakri, Tilo Niemann, Andr\'e Euler, Julia E Vogt
The paper introduces Report Supervision (R‑Super), a framework that uses radiology reports to supervise tumor segmentation models. By incorporating loss functions that align segmentation outputs with report‑derived tumor counts, sizes, and locations, R‑Super improves detection and segmentation performance. Experiments on kidney and pancreatic tumors show up to a 15% increase in F1‑Score and DSC compared to mask‑only training, outperforming methods like CLIP and multi‑task learning.
By Pedro R. A. S. Bassia, Wenxuan Li, Jakob Wasserthal, Jieneng Chen, Xinze Zhou, Zheren Zhu, Chuntung Zhuanga, Sergio Decherchi, Andrea Cavalli, Kang Wang, Yang Yang, Alan Yuille, Zongwei Zhou
arXiv:2609.00396v1 Announce Type: new
Abstract: Histopathological whole slide images (WSIs) are central to cancer diagnosis, but their gigapixel scale, tissue heterogeneity, weak slide-level supervis...
By Chad Wong, Sicheng Chen, Tianyi Zhang, Enhui Chai, Yueming Jin, Zeyu Liu, Fei Xia
Colorectal cancer (CRC) is the third most common cancer worldwide and the second leading cause of cancer-related deaths globally, with approximately 1,926,425 new cases and 904,019 deaths reported in 2022. Accurate histologic grading plays a critical role in prognosis and treatment planning for colorectal adenocarcinoma.
arXiv:2607.12750v3 Announce Type: replace
Abstract: Colorectal cancer (CRC) is the third most common cancer worldwide and the second leading cause of cancer-related deaths globally, with approximatel...
By Elham Amjadi, Amin Bahreini, Sayed Mohammad Hasan Emami, Sayyed Mohammadreza Hakimian, Alireza Fahim, Hojjatollah Rahimi, Hamidreza Bolhasani
arXiv:2607. 03253v1 Announce Type: cross Abstract: As hematoxylin & eosin (H&E) staining constitutes the primary entry point in routine diagnostic workflows, computer-aided diagnosis from whole-slide H&E images is of particular clinical relevance.
By Ivica Kopriva, Dario Sitnik, Arijana Pacic, Karolina Krstanac, Irena Veliki Dalic, Marijana Popovic Hadzija
arXiv:2607. 13826v1 Announce Type: cross Abstract: Accurate determination of pancreatic ductal adenocarcinoma (PDAC) resectability relies on evaluating how the tumor interacts with major peripancreatic vessels on CT imaging, yet expert assessment often shows substantial variability.
By Vincent Ochs, Christoph Kuemmerli, Florentin Bieder, Julia Wolleb, Joel L. Lavanchy, Julia Ruppel, Jan Liechti, Stephanie Taha-Mehlitz, Christian Andreas Nebiker, Beat Mueller, Giuseppe Kito Fusai, Joerg-Matthias Pollok, Anas Taha, Philippe C. Cattin, Sebastian Staubli
arXiv:2511. 01143v2 Announce Type: replace-cross Abstract: Early and accurate segmentation of colorectal polyps is critical for reducing colorectal cancer mortality, which has been extensively explored by academia and industry.
By Ziyi Wang, Yuanmei Zhang, Baoying Ye, Yimei Jiang, Leilei Gu, Suncheng Xiang
arXiv:2602. 04819v5 Announce Type: replace-cross Abstract: Accurate risk stratification of precancerous polyps during routine colonoscopy screening is a key strategy to reduce the incidence of colorectal cancer (CRC).
By Aqsa Sultana, Rayan Afsar, Ahmed Rahu, Surendra P. Singh, Brian Shula, Brandon Combs, Derrick Forchetti, Vijayan K. Asari
arXiv:2604.27697v2 Announce Type: replace-cross
Abstract: Peritoneal metastases (PM) are staged using the surgically determined Peritoneal Cancer Index (sPCI), which requires invasive laparoscopic as...
By Pieter C. Gort, Lotte J. S. Fleurkens-Ewals, Lenah D. Kampmeijer, Anna F. van Herwijnen, Marion W. Tops-Welten, Cris H. B. Claessens, Joost Nederend, Ignace H. J. T. De Hingh, Max J. Lahaye, Misha D. P. Luyer, Fons van der Sommen
HERO (Histology Encoder for Robust Representation in Oncology) is a ViT‑G/14 pathology foundation model trained with DINO and iBOT objectives and refined using high‑resolution Gram anchoring on a 500‑million‑tile corpus from about 575,000 clinical whole‑slide images. It demonstrates superior robustness to center, scanner, and stain variation compared to other state‑of‑the‑art foundation models, while maintaining competitive performance on tile‑level classification, segmentation, and gene‑expression prediction. Across 39 slide‑level clinical tasks, HERO ranks first on average and achieves the best average rank across six benchmark frameworks under an equal‑weighted analysis.
By Zhi Li (Caris Life Sciences, Irving, TX, United States), Eghbal Amidi (Caris Life Sciences, Irving, TX, United States), Yating Cheng (Caris Life Sciences, Irving, TX, United States), Tyson Dawson (Caris Life Sciences, Irving, TX, United States), Gorkem Can Ates (Caris Life Sciences, Irving, TX, United States), Shuzhen Kuang (Caris Life Sciences, Irving, TX, United States), Norsang Lama (Caris Life Sciences, Irving, TX, United States), Md Ashequr Rahman (Caris Life Sciences, Irving, TX, United States), Zhiying Lu (Caris Life Sciences, Irving, TX, United States), Elisabeth K. Kong (Caris Life Sciences, Irving, TX, United States), Milan Radovich (Caris Life Sciences, Irving, TX, United States), David Spetzler (Caris Life Sciences, Irving, TX, United States), Matthew Oberley (Caris Life Sciences, Irving, TX, United States), George W. Sledge (Caris Life Sciences, Irving, TX, United States), Ming Chen (Caris Life Sciences, Irving, TX, United States)